Tamara Tilburgs

Tamara Tilburgs

Auto-generated profile, based on publicly available information

Tamara Tilburgs

Division of Immunobiology, Cincinnati Children's Hospital Medical Center

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2008 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TTTamara Tilburgs
Tamara Tilburgs
DRDave L. Roelen
Dave L. Roelen
BMBarbara J. van der Mast
Barbara J. van der Mast
GGGodelieve M. de Groot-Swings
Godelieve M. de Groot-Swings
CKCarin Kleijburg
Carin Kleijburg
FCFrans H. Claas
Frans H. Claas
During pregnancy, the maternal immune system has to tolerate the persistence of fetal alloantigens. Many mechanisms contribute to the prevention of a destructive immune response mediated by maternal alloreactive lymphocytes directed against the allogeneic fetus. Murine studies suggest that CD4+CD25+ T cells provide mechanisms of specific immune tolerance to fetal alloantigens during pregnancy. Previous studies by our group demonstrate that a significantly higher percentage of activated T cells and CD4+CD25bright T cells are present in decidual tissue in comparison with maternal peripheral blood in human pregnancy. In this study, we examined the phenotypic and functional properties of CD4+CD25bright T cells derived from maternal peripheral blood and decidual tissue. Depletion of CD4+CD25bright T cells from maternal peripheral blood demonstrates regulation to third party umbilical cord blood cells comparable to nonpregnant controls, whereas the suppressive capacity to umbilical cord blood cells of her own child is absent. Furthermore, maternal peripheral blood shows a reduced percentage of CD4+CD25brightFOXP3+ and CD4+CD25brightHLA-DR+ cells compared with peripheral blood of nonpregnant controls. In contrast, decidual lymphocyte isolates contain high percentages of CD4+CD25bright T cells with a regulatory phenotype that is able to down-regulate fetus-specific and fetus-nonspecific immune responses. These data suggest a preferential recruitment of fetus-specific regulatory T cells from maternal peripheral blood to the fetal-maternal interface, where they may contribute to the local regulation of fetus-specific responses.

Verified
Journal Article
Open access
PDF file
SNShu-Wing Ng
Shu-Wing Ng
GNGabriella A. Norwitz
Gabriella A. Norwitz
MPMihaela Pavlicev
Mihaela Pavlicev
TTTamara Tilburgs
Tamara Tilburgs
CSCarlos Simon
Carlos Simon
ENErrol Norwitz
Errol Norwitz
Interventions to prevent pregnancy complications have been largely unsuccessful. We suggest this is because the foundation for a healthy pregnancy is laid prior to the establishment of the pregnancy at the time of endometrial decidualization. Humans are one of only a few mammalian viviparous species in which decidualization begins during the latter half of each menstrual cycle and is therefore independent of the conceptus. Failure to adequately prepare (decidualize) the endometrium hormonally, biochemically, and immunologically in anticipation of the approaching blastocyst—including the downregulation of genes involved in the pro- inflammatory response and resisting tissue invasion along with the increased expression of genes that promote angiogenesis, foster immune tolerance, and facilitate tissue invasion—leads to abnormal implantation/placentation and ultimately to adverse pregnancy outcome. We hypothesize, therefore, that the primary driver of pregnancy health is the quality of the soil, not the seed.

15 February 2011 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
BHBrandy L. Houser
Brandy L. Houser
TTTamara Tilburgs
Tamara Tilburgs
JHJonathan Hill
Jonathan Hill
MNMatthew L. Nicotra
Matthew L. Nicotra
JSJack L. Strominger
Jack L. Strominger
Several important events occur at the maternal–fetal interface, including generation of maternal–fetal tolerance, remodeling of the uterine smooth muscle and its spiral arteries and glands, and placental construction. Fetal-derived extravillous trophoblasts come in direct contact with maternal decidual leukocytes. Macrophages represent ∼20% of the leukocytes at this interface. In this study, two distinct subsets of CD14+ decidual macrophages (dMɸs) are found to be present in first-trimester decidual tissue, CD11cHI and CD11cLO. Gene expression analysis by RNA microarray revealed that 379 probes were differentially expressed between these two populations. Analysis of the two subsets revealed several clusters of coregulated genes that suggest distinct functions for these subsets in tissue remodeling, growth, and development. CD11cHI dMɸs express genes associated with lipid metabolism and inflammation, whereas CD11cLO dMɸs express genes associated with extracellular matrix formation, muscle regulation, and tissue growth. The CD11cHI dMɸs also differ from CD11cLO dMɸs in their ability to process protein Ag and are likely to be the major APCs in the decidua. Moreover, these populations each secrete both proinflammatory and anti-inflammatory cytokines that may contribute to the balance that establishes fetal–maternal tolerance. Thus, they do not fit the conventional M1/M2 categorization.

1 April 2017 in Trends in Immunology
Verified
Journal Article
Closed access
Leonardo FerreiraLeonardo Ferreira
Leonardo Ferreira
TMTorsten B. Meissner
Torsten B. Meissner
TTTamara Tilburgs
Tamara Tilburgs
JSJack L. Strominger
Jack L. Strominger

1 November 2009 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
TTTamara Tilburgs
Tamara Tilburgs
SSSicco A. Scherjon
Sicco A. Scherjon
BMBarbara J. van der Mast
Barbara J. van der Mast
GHGeert W. Haasnoot
Geert W. Haasnoot
MVMinke Versteeg-V.D.Voort-Maarschalk
Minke Versteeg-V.D.Voort-Maarschalk
FCFrans H.J. Claas
Frans H.J. Claas

1 April 2006 in Placenta
Verified
Journal Article
Closed access
TTT. Tilburgs
T. Tilburgs
DRD.L. Roelen
D.L. Roelen
BMB.J. van der Mast
B.J. van der Mast
JSJ.J. van Schip
J.J. van Schip
CKC. Kleijburg
C. Kleijburg
SSS.A. Scherjon
S.A. Scherjon